|What:||Teva Presentation at the 2013 RBC Capital Markets Global Healthcare Conference|
|Who:||Jon Congleton, SVP, Global Medicines Group|
|When:||Wednesday, February 27 2013 at 1:30 PM (EST)|
|How:||Live over the Internet – log on to the Web at the address above and register for the|
|event (approximately 10 minutes before). An archive of the webcast will be available|
|on Teva’s website.|
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the 2013 RBC Capital Markets Global Healthcare Conference. Jon Congleton, SVP, Global Medicines Group, will present on Wednesday, February 27, 2013.
About Teva Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012.